Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells
Authors:
Open Access
- 23 August 2010
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (36) , 15886-15891
Abstract
Angiotensin-converting enzyme 2 (ACE2) is a newly discovered homolog of ACE whose actions oppose those of angiotensin II (AngII). However, the underlying mechanisms by which ACE2 effectively suppresses early atherosclerotic lesions remain poorly understood. Here, we show, both in vitro and in vivo, that ACE2 inhibited the development of early atherosclerotic lesions by suppressing the growth of vascular smooth muscle cells (VSMCs) and improving endothelial function. In a relatively large cohort animal study (66 rabbits), aortic segments transfected by Ad-ACE2 showed significantly attenuated fatty streak formation, neointimal macrophage infiltration, and alleviation of impaired endothelial function. Segments also showed decreased expression of monocyte chemoattractant protein 1, lectin-like oxidized low-density lipoprotein receptor 1, and proliferating cell nuclear antigen, which led to the delayed onset of atherosclerotic lesions. At the cellular level, ACE2 significantly modulated AngII-induced growth and migration in human umbilical vein endothelial cells and VSMCs. The antiatherosclerotic effect of ACE2 involved down-regulation of the ERK-p38, JAK-STAT, and AngII-ROS-NF-κB signaling pathways and up-regulation of the PI3K-Akt pathway. These findings revealed the molecular mechanisms of the antiatherosclerotic activity of ACE2 and suggested that modulation of ACE2 could offer a therapeutic option for treating atherosclerosis.Keywords
This publication has 35 references indexed in Scilit:
- Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in miceJournal of Clinical Investigation, 2009
- Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive ratsPharmacological Research, 2009
- AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesisAmerican Journal of Physiology-Cell Physiology, 2009
- Efficacy of topical application of eosin for ulcerated hemangiomasJournal of the American Academy of Dermatology, 2009
- Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in CardiomyocytesHypertension, 2008
- Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase PathwayThe American Journal of Pathology, 2008
- Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor DownregulationCirculation Research, 2008
- Involvement of integrins, MAPK, and NF-κB in regulation of the shear stress-induced MMP-9 expression in endothelial cellsBiochemical and Biophysical Research Communications, 2007
- Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted RatHypertension, 2006
- New Mass Spectrometric Assay for Angiotensin-Converting Enzyme 2 ActivityHypertension, 2006